Survey of Clinical Practice for Irritable Bowel Syndrome in East Asian Countries

Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypot...

Full description

Saved in:
Bibliographic Details
Published inDigestion Vol. 91; no. 1; pp. 99 - 109
Main Authors Fukudo, Shin, Hahm, Ki-Baik, Zhu, Qi, Sollano, Jose D., Rani, Abdul A., Syam, Ari F., Kachintorn, Udom, Suzuki, Hidekazu, Kamiya, Takeshi, Joh, Takashi, Uchiyama, Kazuhiko, Naito, Yuji, Takahashi, Shin'ichi, Kinoshita, Yoshikazu, Ueno, Fumiaki, Yamagami, Hirokazu, Chan, Francis K.L., Fock, Kwong M., Arakawa, Tetsuo
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.
AbstractList Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries.AIMSociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries.Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS.SUBJECTS AND METHODSStudy participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS.Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists.RESULTSSubjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists.This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.CONCLUSIONThis survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.
Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.
Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.
Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries. © 2015 S. Karger AG, Basel
Author Takahashi, Shin'ichi
Kinoshita, Yoshikazu
Rani, Abdul A.
Ueno, Fumiaki
Hahm, Ki-Baik
Fukudo, Shin
Suzuki, Hidekazu
Sollano, Jose D.
Uchiyama, Kazuhiko
Kamiya, Takeshi
Naito, Yuji
Syam, Ari F.
Yamagami, Hirokazu
Fock, Kwong M.
Zhu, Qi
Arakawa, Tetsuo
Kachintorn, Udom
Joh, Takashi
Chan, Francis K.L.
Author_xml – sequence: 1
  givenname: Shin
  surname: Fukudo
  fullname: Fukudo, Shin
  email: sfukudo@med.tohoku.ac.jp
– sequence: 2
  givenname: Ki-Baik
  surname: Hahm
  fullname: Hahm, Ki-Baik
– sequence: 3
  givenname: Qi
  surname: Zhu
  fullname: Zhu, Qi
– sequence: 4
  givenname: Jose D.
  surname: Sollano
  fullname: Sollano, Jose D.
– sequence: 5
  givenname: Abdul A.
  surname: Rani
  fullname: Rani, Abdul A.
– sequence: 6
  givenname: Ari F.
  surname: Syam
  fullname: Syam, Ari F.
– sequence: 7
  givenname: Udom
  surname: Kachintorn
  fullname: Kachintorn, Udom
– sequence: 8
  givenname: Hidekazu
  surname: Suzuki
  fullname: Suzuki, Hidekazu
– sequence: 9
  givenname: Takeshi
  surname: Kamiya
  fullname: Kamiya, Takeshi
– sequence: 10
  givenname: Takashi
  surname: Joh
  fullname: Joh, Takashi
– sequence: 11
  givenname: Kazuhiko
  surname: Uchiyama
  fullname: Uchiyama, Kazuhiko
– sequence: 12
  givenname: Yuji
  surname: Naito
  fullname: Naito, Yuji
– sequence: 13
  givenname: Shin'ichi
  surname: Takahashi
  fullname: Takahashi, Shin'ichi
– sequence: 14
  givenname: Yoshikazu
  surname: Kinoshita
  fullname: Kinoshita, Yoshikazu
– sequence: 15
  givenname: Fumiaki
  surname: Ueno
  fullname: Ueno, Fumiaki
– sequence: 16
  givenname: Hirokazu
  surname: Yamagami
  fullname: Yamagami, Hirokazu
– sequence: 17
  givenname: Francis K.L.
  surname: Chan
  fullname: Chan, Francis K.L.
– sequence: 18
  givenname: Kwong M.
  surname: Fock
  fullname: Fock, Kwong M.
– sequence: 19
  givenname: Tetsuo
  surname: Arakawa
  fullname: Arakawa, Tetsuo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25632923$$D View this record in MEDLINE/PubMed
BookMark eNpt0UtPGzEQAGC3TQWB5tA7Qpa4lMMWP9f2ESJeElKR0p5XtndSmW5ssHdb5d-zKAkSqKeRNd-MxjMHaBJTBIS-UvKdUmnOCCG8NkTpD2hmlOacasIJ1fQjmlLBaGV0rT69ySkxQVNCKKuYZnwfHZTy8PI0gu-hfSZrzgzjU3S_GPJfWOO0xPMuxOBth--z9X3wgJcp49ucQ29dB_gi_YMOL9axzWkFOER8aUuPz0uwEc_TEPscoHxBn5e2KzDbxkP06-ry5_ymuvtxfTs_v6s8r2VfUesEpdobCq5tbauVNK0mlnurpHWetx5qKZ3ixgFzWhAnhVeEKUUlaOCH6Num72NOTwOUvlmF4qHrbIQ0lIbWkgmhieEjPXlHH9KQ4zjdRtVSCTOq460a3Ara5jGHlc3rZrerEZxtgM-plAzLxo-b6UMaP25D11DSvFyreb3WWHH6rmLX9H_2aGP_2Pwb8qvcpp8BSHmVjg
CODEN DIGEBW
CitedBy_id crossref_primary_10_1111_nmo_14581
crossref_primary_10_1007_s00535_016_1165_5
crossref_primary_10_1111_nmo_13131
crossref_primary_10_1097_SGA_0000000000000330
crossref_primary_10_1111_nmo_13023
crossref_primary_10_3390_nu14102015
crossref_primary_10_5056_jnm22037
crossref_primary_10_5217_ir_2017_15_2_236
crossref_primary_10_1111_nmo_13402
crossref_primary_10_1002_jgh3_12665
crossref_primary_10_1053_j_gastro_2020_04_014
crossref_primary_10_1111_apt_16467
crossref_primary_10_1371_journal_pone_0129345
crossref_primary_10_1177_2156587216628374
Cites_doi 10.1053/j.gastro.2006.03.008
10.1053/j.gastro.2005.11.061
10.1053/j.gastro.2004.03.012
10.1038/ajg.2009.341
10.1111/j.1440-1746.2006.04136.x
10.1111/j.1365-2036.2009.04087.x
10.1371/journal.pone.0054183
10.1111/j.1365-2036.2004.02128.x
10.1111/j.1440-1746.2010.06338.x
10.1007/s00535-009-0168-x
10.1053/gast.2000.16484
10.1002/ibd.20059
10.1002/14651858.CD003460.pub3
10.1038/ajgsup.2014.6
10.1038/ajg.2009.621
10.1038/nature08937
10.1111/j.1365-2036.2005.02463.x
10.1016/j.cgh.2014.08.026
10.1038/ajg.2010.58
10.1111/j.1365-2982.2011.01668.x
10.1136/gut.42.3.414
10.1136/gut.2008.167270
10.1016/j.cgh.2013.11.024
10.1111/nmo.12402
10.1111/j.1365-2036.2011.04715.x
10.1111/j.1572-0241.2002.07027.x
10.1016/S0002-9270(03)00705-6
10.1111/apt.12938
10.1111/j.1365-2982.2011.01732.x
10.1016/j.cgh.2012.02.029
10.1111/j.1365-2036.2006.02938.x
10.1097/MCG.0b013e318150d006
10.1111/j.1440-1746.2010.06353.x
10.1001/archinternmed.2009.22
10.1111/j.0269-2813.2004.01862.x
10.1002/14651858.CD006442.pub2
10.1111/apt.12942
10.1111/j.1440-1746.2011.06635.x
10.1053/j.gastro.2005.09.071
ContentType Journal Article
Copyright 2015 S. Karger AG, Basel
2015 S. Karger AG, Basel.
Copyright (c) 2015 S. Karger AG, Basel
Copyright_xml – notice: 2015 S. Karger AG, Basel
– notice: 2015 S. Karger AG, Basel.
– notice: Copyright (c) 2015 S. Karger AG, Basel
CorporateAuthor The International Gastrointestinal Consensus Symposium Study Group
International Gastrointestinal Consensus Symposium Study Group
CorporateAuthor_xml – name: The International Gastrointestinal Consensus Symposium Study Group
– name: International Gastrointestinal Consensus Symposium Study Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
S0X
7X8
DOI 10.1159/000369078
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISBN 9783318030181
331803018X
EISSN 1421-9867
EndPage 109
ExternalDocumentID 3584140081
25632923
10_1159_000369078
369078
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Singapore
Asia
China
Japan
Philippines
Republic of Korea
Indonesia
GeographicLocations_xml – name: Singapore
– name: Republic of Korea
– name: Asia
– name: Philippines
– name: Japan
– name: China
– name: Indonesia
GroupedDBID ---
.55
.GJ
0R~
0~5
0~B
29G
30W
327
34G
36B
39C
3O.
3V.
4.4
53G
5GY
5RE
7X7
88E
8AO
8FI
8FJ
8UI
AAYIC
AAYJJ
ABJNI
ABPAZ
ABUWG
ACGFS
ACPRK
ACPSR
ADAGL
ADBBV
AENEX
AEYAO
AFFNX
AFJJK
AFKRA
AFOSN
AHMBA
AI.
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APPQY
AZPMC
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CYUIP
DU5
E0A
EBS
EJD
EMB
EMOBN
F5P
FB.
FYUFA
HMCUK
HZ~
IY7
KUZGX
L7B
M1P
N9A
O1H
O9-
PQQKQ
PROAC
PSQYO
RIG
RKO
RXVBD
S0X
SV3
UJ6
UKHRP
VH1
X7M
ZGI
ZXP
AAYXX
ABBTS
ABWCG
ACQXL
AFSIO
AHFRZ
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c365t-1ab4118c91ebddad8759d80a3ca75abc3dce655b739be2b840b54c7027715e8e3
IEDL.DBID 7X7
ISBN 9783318030174
3318030171
ISSN 0012-2823
1421-9867
IngestDate Thu Jul 10 19:16:14 EDT 2025
Sat Aug 23 12:29:37 EDT 2025
Mon Jul 21 06:05:00 EDT 2025
Thu Apr 24 23:01:16 EDT 2025
Tue Aug 05 11:59:34 EDT 2025
Thu Aug 29 12:04:39 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Functional gastrointestinal disorders
East Asian countries
Irritable bowel syndrome
Rome III criteria
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
https://www.karger.com/Services/SiteLicenses
2015 S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c365t-1ab4118c91ebddad8759d80a3ca75abc3dce655b739be2b840b54c7027715e8e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.karger.com/Article/Pdf/369078
PMID 25632923
PQID 1652465749
PQPubID 2207
PageCount 11
ParticipantIDs proquest_miscellaneous_1652448093
karger_primary_369078
pubmed_primary_25632923
proquest_journals_1652465749
crossref_citationtrail_10_1159_000369078
crossref_primary_10_1159_000369078
PublicationCentury 2000
PublicationDate 20150100
2015-00-00
20150101
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 20150100
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle Digestion
PublicationTitleAlternate Digestion
PublicationYear 2015
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Güçlü M, Pourbagher A, Serin E, et al: Ultrasonographic evaluation of gallbladder functions in patients with irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:1309-1312.1687231510.1111/j.1440-1746.2006.04136.x
Kim ES, Cheon JH, Park JJ, Moon CM, Hong SP, Kim TI, Kim WH: Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010;25:1232-1238.2059424910.1111/j.1440-1746.2010.06338.x
Tack J: Systematic review: the efficacy of treatments for irritable bowel syndrome: a European perspective. Aliment Pharmacol Ther 2006;24:183-205.1684244810.1111/j.1365-2036.2006.02938.x
Cash BD, Schoenfeld P, Chey WD: The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:S7-S261242555310.1111/j.1572-0241.2002.07027.x
Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T, et al: High prevalence of irritable bowel syndrome in medical outpatients in Japan. J Clin Gastroenterol 2008;42:1010-1016.1860729510.1097/MCG.0b013e318150d006
Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325-332.1909182310.1136/gut.2008.167270
Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454-2459.1463834810.1016/S0002-9270(03)00705-6
Drossman D, Szigethy E: The narcotic bowel syndrome: a recent update. Am J Gastroenterol 2014;2:22-30.2520760910.1038/ajgsup.2014.6
Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V: Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365-1375.1593236710.1111/j.1365-2036.2005.02463.x
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006;130:1480-1491.1667856110.1053/j.gastro.2005.11.061
Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB: Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615-621.1535290910.1111/j.1365-2036.2004.02128.x
Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW: Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011;8:CD003460.2183394510.1002/14651858.CD003460.pub3
Okumura T, Tanno S, Ohhira M, Tanno S: Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 2010;45:187-194.1999785410.1007/s00535-009-0168-x
Drossman DA: Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol 2009;104:2897-29021995611510.1038/ajg.2009.341
Jellema P, van der Windt DA, Schellevis FG, et al: Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009;30:695-706.1957576310.1111/j.1365-2036.2009.04087.x
Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.1667855310.1053/j.gastro.2006.03.008
Sperber AD, Gwee KA, Hungin AP, Corazziari E, Fukudo S, Gerson C, Ghoshal UC, Kang JY, Levy RL, Schmulson M, Dumitrascu D, Gerson MJ, Chen M, Myung SJ, Quigley EM, Whorwell PJ, Zarzar K, Whitehead WE: Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations: a Rome Foundation working team report. Aliment Pharmacol Ther 2014;40:1094-1102.2517599810.1111/apt.12942
Bijkerk CJ, Muris JW, Knottnerus JA, et al: Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-251.1498437010.1111/j.0269-2813.2004.01862.x
Schmulson M, Corazziari E, Ghoshal UC, Myung SJ, Gerson CD, Quigley EM, Gwee KA, Sperber AD: A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil 2014;26:1368-1385.2508745110.1111/nmo.12402
Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R: Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol 2014, Epub ahead of print.2515892510.1016/j.cgh.2014.08.026
Fukudo S, Hongo M, Kaneko H, Ueno R: Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil 2011;23:544-e205.2130343010.1111/j.1365-2982.2011.01668.x
Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE: Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414-420.957735110.1136/gut.42.3.414
Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, Li YQ: A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 2013;8:e54183.2334982010.1371/journal.pone.0054183
Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, Sperber AD: Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006;130:1435-1446.1667855710.1053/j.gastro.2005.09.071
Spiegel BM, DeRosa VP, Gralnek IM, et al: Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004;126:1721-1732.1518816710.1053/j.gastro.2004.03.012
Limsui D, Pardi DS, Camilleri M, et al: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-181.1720669910.1002/ibd.20059
Miura S, Sugano K, Kinoshita Y, Fock KM, Goh KL, Gibson P, et al: Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices. J Gastroenterol Hepatol 2011;26(suppl 3):2-11.2144369910.1111/j.1440-1746.2011.06635.x
Canavan C, West J, Card T: Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-1034.2519990410.1111/apt.12938
Hanevik K, Dizdar V, Langeland N, et al: Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2011;34:259-260.2167921110.1111/j.1365-2036.2011.04715.x
Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S: Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil 2011;23:754-e332.2161562310.1111/j.1365-2982.2011.01732.x
Lovell RM, Ford AC: Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-721.2242608710.1016/j.cgh.2012.02.029
Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660.1098275810.1053/gast.2000.16484
Ford AC, Chey WD, Talley NJ, et al: Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651-658.1936499410.1001/archinternmed.2009.22
Zijdenbos IL, de Wit NJ, van der Heijden GJ, et al: Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009;1:CD006442.1916028610.1002/14651858.CD006442.pub2
Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G: Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-912.2037615010.1038/nature08937
Jung HK, Choung RS, Locke GR 3rd, et al: Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-661.1986195510.1038/ajg.2009.621
Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K: Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2014;12:953-959.e4.2431588210.1016/j.cgh.2013.11.024
Schmulson M, Adeyemo M, Gutiérrez-Reyes G, Charúa-Guindic L, Farfán-Labonne B, Ostrosky-Solis F, Díaz-Anzaldúa A, Medina L, Chang L: Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-932.2017969310.1038/ajg.2010.58
Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M, Asian Neurogastroenterology and Motility Association: Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1189-1205.2059424510.1111/j.1440-1746.2010.06353.x
ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – reference: Ford AC, Chey WD, Talley NJ, et al: Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651-658.1936499410.1001/archinternmed.2009.22
– reference: Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW: Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011;8:CD003460.2183394510.1002/14651858.CD003460.pub3
– reference: Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S: Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil 2011;23:754-e332.2161562310.1111/j.1365-2982.2011.01732.x
– reference: Sperber AD, Gwee KA, Hungin AP, Corazziari E, Fukudo S, Gerson C, Ghoshal UC, Kang JY, Levy RL, Schmulson M, Dumitrascu D, Gerson MJ, Chen M, Myung SJ, Quigley EM, Whorwell PJ, Zarzar K, Whitehead WE: Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations: a Rome Foundation working team report. Aliment Pharmacol Ther 2014;40:1094-1102.2517599810.1111/apt.12942
– reference: Tack J: Systematic review: the efficacy of treatments for irritable bowel syndrome: a European perspective. Aliment Pharmacol Ther 2006;24:183-205.1684244810.1111/j.1365-2036.2006.02938.x
– reference: Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE: Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414-420.957735110.1136/gut.42.3.414
– reference: Bijkerk CJ, Muris JW, Knottnerus JA, et al: Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-251.1498437010.1111/j.0269-2813.2004.01862.x
– reference: Miura S, Sugano K, Kinoshita Y, Fock KM, Goh KL, Gibson P, et al: Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices. J Gastroenterol Hepatol 2011;26(suppl 3):2-11.2144369910.1111/j.1440-1746.2011.06635.x
– reference: Okumura T, Tanno S, Ohhira M, Tanno S: Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 2010;45:187-194.1999785410.1007/s00535-009-0168-x
– reference: Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB: Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615-621.1535290910.1111/j.1365-2036.2004.02128.x
– reference: Jung HK, Choung RS, Locke GR 3rd, et al: Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-661.1986195510.1038/ajg.2009.621
– reference: Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660.1098275810.1053/gast.2000.16484
– reference: Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.1667855310.1053/j.gastro.2006.03.008
– reference: Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G: Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-912.2037615010.1038/nature08937
– reference: Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, Li YQ: A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 2013;8:e54183.2334982010.1371/journal.pone.0054183
– reference: Hanevik K, Dizdar V, Langeland N, et al: Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2011;34:259-260.2167921110.1111/j.1365-2036.2011.04715.x
– reference: Drossman D, Szigethy E: The narcotic bowel syndrome: a recent update. Am J Gastroenterol 2014;2:22-30.2520760910.1038/ajgsup.2014.6
– reference: Kim ES, Cheon JH, Park JJ, Moon CM, Hong SP, Kim TI, Kim WH: Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010;25:1232-1238.2059424910.1111/j.1440-1746.2010.06338.x
– reference: Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V: Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365-1375.1593236710.1111/j.1365-2036.2005.02463.x
– reference: Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T, et al: High prevalence of irritable bowel syndrome in medical outpatients in Japan. J Clin Gastroenterol 2008;42:1010-1016.1860729510.1097/MCG.0b013e318150d006
– reference: Güçlü M, Pourbagher A, Serin E, et al: Ultrasonographic evaluation of gallbladder functions in patients with irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:1309-1312.1687231510.1111/j.1440-1746.2006.04136.x
– reference: Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R: Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol 2014, Epub ahead of print.2515892510.1016/j.cgh.2014.08.026
– reference: Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K: Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2014;12:953-959.e4.2431588210.1016/j.cgh.2013.11.024
– reference: Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M, Asian Neurogastroenterology and Motility Association: Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1189-1205.2059424510.1111/j.1440-1746.2010.06353.x
– reference: Drossman DA: Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol 2009;104:2897-29021995611510.1038/ajg.2009.341
– reference: Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325-332.1909182310.1136/gut.2008.167270
– reference: Canavan C, West J, Card T: Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-1034.2519990410.1111/apt.12938
– reference: Zijdenbos IL, de Wit NJ, van der Heijden GJ, et al: Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009;1:CD006442.1916028610.1002/14651858.CD006442.pub2
– reference: Lovell RM, Ford AC: Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-721.2242608710.1016/j.cgh.2012.02.029
– reference: Jellema P, van der Windt DA, Schellevis FG, et al: Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009;30:695-706.1957576310.1111/j.1365-2036.2009.04087.x
– reference: Schmulson M, Adeyemo M, Gutiérrez-Reyes G, Charúa-Guindic L, Farfán-Labonne B, Ostrosky-Solis F, Díaz-Anzaldúa A, Medina L, Chang L: Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-932.2017969310.1038/ajg.2010.58
– reference: Spiegel BM, DeRosa VP, Gralnek IM, et al: Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004;126:1721-1732.1518816710.1053/j.gastro.2004.03.012
– reference: Schmulson M, Corazziari E, Ghoshal UC, Myung SJ, Gerson CD, Quigley EM, Gwee KA, Sperber AD: A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil 2014;26:1368-1385.2508745110.1111/nmo.12402
– reference: Fukudo S, Hongo M, Kaneko H, Ueno R: Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil 2011;23:544-e205.2130343010.1111/j.1365-2982.2011.01668.x
– reference: Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, Sperber AD: Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006;130:1435-1446.1667855710.1053/j.gastro.2005.09.071
– reference: Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454-2459.1463834810.1016/S0002-9270(03)00705-6
– reference: Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006;130:1480-1491.1667856110.1053/j.gastro.2005.11.061
– reference: Cash BD, Schoenfeld P, Chey WD: The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:S7-S261242555310.1111/j.1572-0241.2002.07027.x
– reference: Limsui D, Pardi DS, Camilleri M, et al: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-181.1720669910.1002/ibd.20059
– ident: ref1
  doi: 10.1053/j.gastro.2006.03.008
– ident: ref2
  doi: 10.1053/j.gastro.2005.11.061
– ident: ref20
  doi: 10.1053/j.gastro.2004.03.012
– ident: ref36
  doi: 10.1038/ajg.2009.341
– ident: ref19
  doi: 10.1111/j.1440-1746.2006.04136.x
– ident: ref25
  doi: 10.1111/j.1365-2036.2009.04087.x
– ident: ref14
  doi: 10.1371/journal.pone.0054183
– ident: ref16
  doi: 10.1111/j.1365-2036.2004.02128.x
– ident: ref17
  doi: 10.1111/j.1440-1746.2010.06338.x
– ident: ref11
  doi: 10.1007/s00535-009-0168-x
– ident: ref4
  doi: 10.1053/gast.2000.16484
– ident: ref22
  doi: 10.1002/ibd.20059
– ident: ref30
  doi: 10.1002/14651858.CD003460.pub3
– ident: ref38
  doi: 10.1038/ajgsup.2014.6
– ident: ref18
  doi: 10.1038/ajg.2009.621
– ident: ref8
  doi: 10.1038/nature08937
– ident: ref24
  doi: 10.1111/j.1365-2036.2005.02463.x
– ident: ref35
  doi: 10.1016/j.cgh.2014.08.026
– ident: ref13
  doi: 10.1038/ajg.2010.58
– ident: ref34
  doi: 10.1111/j.1365-2982.2011.01668.x
– ident: ref12
  doi: 10.1136/gut.42.3.414
– ident: ref27
  doi: 10.1136/gut.2008.167270
– ident: ref32
  doi: 10.1016/j.cgh.2013.11.024
– ident: ref39
  doi: 10.1111/nmo.12402
– ident: ref37
  doi: 10.1111/j.1365-2036.2011.04715.x
– ident: ref23
  doi: 10.1111/j.1572-0241.2002.07027.x
– ident: ref15
  doi: 10.1016/S0002-9270(03)00705-6
– ident: ref5
  doi: 10.1111/apt.12938
– ident: ref33
  doi: 10.1111/j.1365-2982.2011.01732.x
– ident: ref3
  doi: 10.1016/j.cgh.2012.02.029
– ident: ref28
  doi: 10.1111/j.1365-2036.2006.02938.x
– ident: ref26
  doi: 10.1097/MCG.0b013e318150d006
– ident: ref9
  doi: 10.1111/j.1440-1746.2010.06353.x
– ident: ref21
  doi: 10.1001/archinternmed.2009.22
– ident: ref29
  doi: 10.1111/j.0269-2813.2004.01862.x
– ident: ref31
  doi: 10.1002/14651858.CD006442.pub2
– ident: ref7
  doi: 10.1111/apt.12942
– ident: ref10
  doi: 10.1111/j.1440-1746.2011.06635.x
– ident: ref6
  doi: 10.1053/j.gastro.2005.09.071
SSID ssj0012943
Score 2.1508813
Snippet Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues...
Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues...
SourceID proquest
pubmed
crossref
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 99
SubjectTerms Asia - ethnology
China - ethnology
Cohort Studies
Consensus Report
Cross-Cultural Comparison
Gastroenterology - methods
Humans
Indonesia
Irritable Bowel Syndrome - diagnosis
Irritable Bowel Syndrome - therapy
Japan - ethnology
Philippines - ethnology
Practice Patterns, Physicians' - statistics & numerical data
Republic of Korea - ethnology
Singapore - ethnology
Surveys and Questionnaires
Title Survey of Clinical Practice for Irritable Bowel Syndrome in East Asian Countries
URI https://karger.com/doi/10.1159/000369078
https://www.ncbi.nlm.nih.gov/pubmed/25632923
https://www.proquest.com/docview/1652465749
https://www.proquest.com/docview/1652448093
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8QwEB68EF_E29VVooj4Umybpm2eZJUVFZTFA_at5FoQ11b3UPbfm2mzFUF9bYc8ZJLMfHN8A3AUaGQd46mntMI0Iws86WvqcUGpNQfc7yXYnHx7F189RTdd1nUBt6Erq5y-ieVDrQuFMfLTIGZhFLMk4mdv7x5OjcLsqhuhMQvzSF2Gpzrp1oDLmjJXNRdgC3JIHbOQteCnJRGLBYbpD3u08ILl14O_vc3S6lyuwLJzF0mr0u8qzJh8DdZbuYXKrxNyTMoCzjIyvgaLty5Pvg6dh_Hgw0xI0SOO-LNPOq4filg3lVwPMCgg-4acF5-mTx4ccQF5zklbDEekhc2VBDvWceLWcAOeLtuPF1eem53gKRqzkRcIGVnsoHhgpNZCW1jCdeoLqkTChFRUKxMzJhPKpQmlhXmSRSrBjG7ATGroJszlRW62gUQ9P9YqCTWPhQVzgsdKMKtQPzAmZJo14GS6g5lyxOI436KflQCD8aze7AYc1qJvFZvGb0IblRpqken35lQrmbtow-z7WDTgoP5trwjmPURuirGTiVKf0wZsVdqsl7YeHw2tk7vz_-K7sGQ9JVbFXpowNxqMzZ71RkZyvzxy-zB_3r7r3H8B3JXbyg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VgoBLBX2xUMAgQFyiJnGcxAeEFmi1S7tVpbbS3oJfKyGWpOyDav9UfyMziROEBNx6TSwfPGPP980T4FVkqeuYzANjDYUZRRTo0PJAKs7RHMhwklFx8ugkHVwkn8divAbXbS0MpVW2b2L9UNvKkI98P0pFnKQiS-T7yx8BTY2i6Go7QqNRiyO3ukLKNn83_ITyfR3HhwfnHweBnyoQGJ6KRRApnSCqNjJy2lplEbBLm4eKG5UJpQ23xqVC6IxL7WKNBEiLxGQU64yEyx3HfW_BbTS8IZG9bNwRPDSdPksvopLnmPtORogY9uvGL0hE8z_s351vlO49-ze6ra3c4QPY8PCU9Rt9eghrrtyErX6J1Pz7ir1hdcJo7YnfhLsjH5ffgtOz5eynW7Fqwnyj0Sk79fVXDGExG87ICaGnjn2ortyUnflGCexryQ7UfMH6VMzJqEKeJnzNt-HiRk51B9bLqnSPgCWTMLUmi61MFZJHJVOjBCpQGDkXCyt68LY9wcL4RuY0T2Na1IRGyKI77B687JZeNt07_rZouxFDt6T9vtdKpfAXe178VsMevOh-45WkOIsqXbX0a5I8lLwHu400u60RYfIYQfXj_2_-HO4NzkfHxfHw5OgJ3EeUJhq_zx6sL2ZL9xSR0EI_q9WPwZeb1vdfGRwX9A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VLap6QdAWulDAIEBcok3sOIkPFdrSXXUpXa0olXoLfq2EWJKyD6r9a_y6jhMnCAm49ZqMfPCM7W9e3wC8ioxjHRNZoI12aUYeBSo0LBCSMXwORDhNXXPy2Tg5uYg_XPLLDfjV9MK4ssrmTqwualNqFyPvRQmnccLTWPSmvixicjx8d_UjcBOkXKa1GadRm8ipXV-j-7Y4HB2jrl9TOhx8fn8S-AkDgWYJXwaRVDEibC0iq4yRBsG7MFkomZYpl0ozo23CuUqZUJYqdIYUj3Xq8p4Rt5lluO4d2EydV9SBzaPBePKpzWHQpmYvcg3QlHleI8QPvYoGBt3S7I_X8O43V_w9_zfWrd684X2458Eq6dfW9QA2bLEDu_0CHfXva_KGVOWjVVx-B7bOfJZ-Fybnq_lPuybllHja0RmZ-G4sgiCZjOYuJKFmlhyV13ZGzj1tAvlakIFcLEnftXYS1y_v5n0t9uDiVvb1IXSKsrD7QOJpmBidUiMSia6kFImWHM0pjKyl3PAuvG12MNee1txN15jllXvDRd5udhdetqJXNZfH34T2ajW0Is33g0YruT_mi_y3UXbhRfsbD6jLusjClisvE2ehYF14VGuzXRrxJqMIsR__f_HnsIW2nn8cjU-fwDZCNl4HgQ6gs5yv7FOERUv1zNsfgS-3bfI393Ydjw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Survey+of+clinical+practice+for+irritable+bowel+syndrome+in+East+asian+countries&rft.jtitle=Digestion&rft.au=Fukudo%2C+Shin&rft.au=Hahm%2C+Ki-Baik&rft.au=Zhu%2C+Qi&rft.au=Sollano%2C+Jose+D&rft.date=2015&rft.eissn=1421-9867&rft.volume=91&rft.issue=1&rft.spage=99&rft_id=info:doi/10.1159%2F000369078&rft_id=info%3Apmid%2F25632923&rft.externalDocID=25632923
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-2823&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-2823&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-2823&client=summon